IDEAYA Biosciences Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the rating peer group for IDEAYA Biosciences Inc are shown. The article contains a Q&A section for IDEAYA Biosciences Inc. The ESG score for IDEAYA Biosciences Inc indicates its transparency towards the United Nations Sustainable Development Goals.
IDEAYA Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 2.0, social score of 6.4 and governance score of 8.0.
5.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 602 | SkinBioTherapeutics PLC | 5.6 | High |
| 602 | XOMA Corp | 5.6 | High |
| 627 | IDEAYA Biosciences Inc | 5.5 | High |
| 627 | Advanced Medical Solutions Group PLC | 5.5 | High |
| 627 | Achieve Life Sciences Inc | 5.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does IDEAYA Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes IDEAYA Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes IDEAYA Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes IDEAYA Biosciences Inc offer flexible work?
Sign up for free to unlockDoes IDEAYA Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes IDEAYA Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes IDEAYA Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes IDEAYA Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid IDEAYA Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes IDEAYA Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas IDEAYA Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes IDEAYA Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes IDEAYA Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs IDEAYA Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes IDEAYA Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes IDEAYA Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes IDEAYA Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for IDEAYA Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.